Physician profile
Gregory Stoltzfus
NPI 1114314820
$2,151.23
in general payments reported to CMS, 2019-2025
9 companies · $25.60 in 2025
The $25.60 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.59 · 2020: $141 · 2021: $13.84 · 2022: $1,767 · 2023: $47.55 · 2024: $97.48 · 2025: $25.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,768.08 | 2022-2024 | |
| Cook Incorporated | $140.85 | 2020 | |
| Chiesi USA, INC. | $58.73 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $52.94 | 2019-2022 | |
| Abiomed | $46.98 | 2024 | Impella |
| Pacira Pharmaceuticals Incorporated | $25.60 | 2025 | Exparel |
| Heron Therapeutics, INC. | $24.40 | 2023 | Aponvie |
| Becton, Dickinson and Company | $18.67 | 2024 | Hemosphere |
| Acacia Pharma INC | $14.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Stoltzfus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.